Results 231 to 240 of about 591,468 (262)
Joint Damage Prediction in Non-Severe Hemophilia A with Artificial Intelligence. [PDF]
J Blood MedMarco-Rico A, Calvo-Villas JM, Lopez-Jaime FJ, Canaro Hirnyk M, Nieto-Hernández MDM, Herrero Martín S, Entrena-Ureña L, Marcellini-Antonio S, Diaz-Jordan BL, Jurado-Herrera S, Pérez-González NF, García-Díaz C, García-Candel F, Fernández-Bello I, Mateo-Sotos J, Marco-Vera P. +15 moreeuropepmc +1 more sourceAutoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management
Advanced Science, EarlyView.ABSTRACT
Autoimmune encephalitis (AE) is characterized by immune‐mediated inflammation of the brain parenchyma, presenting with various neurological syndromes, including but not limited to seizures, altered consciousness, neuropsychiatric symptoms, and movement disorders.Suneesh Thilak, David Okoh, William Scotton, Shanika Samarasekera, Vikram Patil, Suresh Renukappa, Andrew Macduff, Subashini Suresh, Rajeev Krishnadas, Tonny Veenith +9 morewiley +1 more sourceCD3xCD20 bispecific antibodies in transformed Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. [PDF]
HemasphereBrocard M, Roos-Weil D, Kanagaratnam L, Hueso T, Bussot L, Papoular B, Tomowiak C, Chevreux S, Crochet G, Vaugeois T, Toussaint E, Ferrero S, Kyriakou C, Quinquenel A, Kapoor P, Durot E. +15 moreeuropepmc +1 more sourceReduced Maintenance DNA Methylation Thresholds Enable Sensitive Reporter Assays for UHRF1 and DNMT1 Inhibition
Advanced Science, EarlyView.The authors engineer colorectal cancer cells with reduced redundancy of UHRF1 and DNMT1, key DNA methylation maintenance factors, lowering the maintenance threshold and sensitizing cells to inhibition. They develop reporter assays driven by endogenous tumor‐suppressor gene promoters with enhanced sensitivity and dynamic range to demethylating drugs ...Cuicui Xia, Ying Cui, Jiongliang Wang, Wenjing Bai, Danyang Wang, Yao Chen, Huahui Guo, Liangyi Zong, Bing Qin, Xintong Cai, Jie Wang, Jing Huang, Scott B. Rothbart, Zufeng Guo, Stephen B. Baylin, Xiangqian Kong +15 morewiley +1 more sourceAllogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study. [PDF]
Blood AdvPeña M, Losi G, Navarro V, Qualls DA, Crombie JL, Mariotti J, Bramanti S, Fabbri N, Serna Á, Serroukh YIM, Balaguer-Rosselló A, Van Der Poel MWM, Hsu YT, Jiménez-Ubieto A, McKinnely C, López-Corral L, Panizo C, Pérez-Simón JA, Rovira M, Saldaña R, Kwon M, Solano C, Valcárcel D, Pascual-Cascón MJ, Noriega V, Sanz J, Sánchez-Salinas A, Jurado M, Calbacho M, Bento L, Albo López C, Perera M, Heras I, Guerreiro M, Balsalobre P, Armand P, Sureda A, Mussetti A. +37 moreeuropepmc +1 more sourceAllogeneic hematopoietic stem cell transplantation in ERCC6L2 disease. [PDF]
Blood AdvHakkarainen M, Sicre de Fontbrune F, Kaaja I, Douglas S, Dalle JH, Risitano AM, Kulasekararaj A, Alsultan A, Cutler C, Ho VT, Hellström-Lindberg E, Mielke S, Myhre AE, Rihani R, Shanap MA, Hashem H, Shimamura A, Rowe RG, Auer F, Beier F, Desnica L, Hough R, Ali Jafri SR, Ayas M, Jardine L, Mellid EF, Corrales I, Richardson D, Özbek NY, Zaniewska-Tekieli A, Gozdzik J, Ryhänen S, Niinimäki R, Jahnukainen K, Salmenniemi U, Kilpivaara O, Wartiovaara-Kautto U. +36 moreeuropepmc +1 more sourceA phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.
BloodDöhner H, Späth D, Saadati M, Fiedler W, Götze K, Koller E, Westermann J, Vogel W, Heuser M, Lübbert M, Tischler HJ, Germing U, Teichmann LL, Fransecky L, Wölfler A, Nachbaur D, Hertenstein B, Schroers R, Martens U, von Harsdorf S, Radsak M, Aschauer G, Weißhaar S, Corbacioglu A, Schrade A, Gaidzik VI, Thol F, Paschka P, Bullinger L, Benner A, Döhner K, Ganser A. +31 moreeuropepmc +1 more source
